PLASMACAP EBA
Live / Registered — Registered (as of 13 Oct 2020)
What this means for you
Registered since 13 Oct 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86019797
- Registration number
- 6172148
- Mark type
- Design + words
- Filed
- 25 Jul 2013
- Published for opposition
- 28 Jul 2020
- Registered
- 13 Oct 2020
- Attorney of record
- Christopher J. Schulte
Goods and services
- Class 001 — Chemicals: Resins, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate ion exchange, mixed mode, and affinity resins
- Class 005 — Pharmaceuticals: Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins
- Class 009 — Scientific and electric apparatus: Protein chromatography equipment for capturing biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate
- Class 037 — Building construction and repair services: Construction of biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services in the field of construction of biopharmaceutical and plasma manufacturing services
- Class 040 — Treatment of materials: Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics
- Class 041 — Education and entertainment services: Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design of chromatography equipment, and design of biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering
Owner
- Evolve Biologics Inc.,, Mississauga, Ontario, CA
- Therapure Biopharma Inc., Mississauga, Ontario, CA
- Therapure Biopharma Inc., Mississauga, Ontario, CA
Prosecution history
- 13 Oct 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Jul 2021 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 01 Jul 2021 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 13 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 27 Aug 2020 — POST PUBLICATION AMENDMENT - ENTERED
- 26 Aug 2020 — ASSIGNED TO PETITION STAFF
- 28 Jul 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jul 2020 — PUBLISHED FOR OPPOSITION
- 09 Jul 2020 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 08 Jul 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Jun 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jun 2020 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 17 Jun 2020 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 02 Jun 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jun 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE